Projet CLOSPORE (Horizon 2020, appel à projets 2014)
Action : Doctoral Networks
Panel : Life Sciences
Statut du projet : CLOSED

Bacterial endospores are the most resistant life-forms on earth and the most important single feature of the genus Clostridium. Thus, whilst the pathogenesis of its notorious pathogens (C. botulinum, C. perfringens and C. difficile) is ascribed to the devastating toxins produced (neurotoxins, endotoxins and cytotoxins), it is their capacity to produce spores that lies at the heart of the diseases they cause. This is because spores play the pivotal role in the spread of infection (eg, C. difficile) and in foodstuff contamination and food poisoning (eg, C. botulinum and C. perfringens). The processes of spore formation (sporulation) and germination (return of the dormant spore to toxin-producing, vegetative cells), therefore, represent key intervention points. On the other hand, the majority of clostridia are entirely benign and can sustainably produce all manner of useful chemicals and fuels. Crucially, the regulation of chemical production is intimately linked to that of sporulation. Spores of benign species may also be used as a delivery system for treating cancer. Yet, despite the spore’s importance, little is known of the developmental processes of sporulation and germination. This is because research and training efforts on Clostridium spores are fragmented and there is no coherence between researchers working on pathogenic and industrially important species. CLOSPORE will address this deficiency by pooling the resources of Europe’s leading universities, research organisations and companies, to create an intersectorial Research and Training Programme that is multi-facetted, interdisciplinary and focused on clostridial spores. Accordingly, CLOSPORE will produce the innovative, applied research leaders of the future, able to tackle the big societal challenges facing Europe and the world.

Mots clés : endospore, clostridium, sporulation, germination, disease transmission, food spoilage, food poisoning, biofuels, cancer therapy, combating microbial resistance

Participants :
- bioMérieux (France) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €
- University of Nottingham (Royaume-Uni) — Coordinator, beneficiary, Enseignement supérieur ou secondaire, subvention : 819863.64 €
- Institut Pasteur (France) — Partner, beneficiary, Recherche, subvention : 525751.2 €
- Nederlands Instituut Voor Zuivel Oonderzoek (Pays-Bas) — Partner, beneficiary, Organismes privés (hors enseignement), subvention : 510748.56 €
- Universidade Nova de Lisboa (Portugal) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 476712.72 €
- Green Biologics (United Kingdom) (Royaume-Uni) — Partner, beneficiary, Organismes privés (hors enseignement), subvention : 273287.88 €
- Atria suomi oy (Finlande) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €
- METabolic Explorer (France) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Saarioinenoy (Finlande) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Snellmanin lihanjalostus oy (Finlande) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Wageningen University & Research (Pays-Bas) — Partner, beneficiary, Recherche, subvention : 255374.28 €
- Lanzatech uk ltd (Royaume-Uni) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Ipsen pharmaceuticals (Royaume-Uni) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €
- University of Helsinki (Finlande) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 538290.72 €
- Hkscan ltd (Finlande) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Corbion (Netherlands) (Pays-Bas) — Partner, beneficiary, Organismes privés (hors enseignement), subvention : 510748.56 €
- Astellas Pharma (United Kingdom) (Royaume-Uni) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €